Newspaper article The Canadian Press

Public Health Agency Gives Spain, Norway ZMapp-Like Drug to Treat Ebola Cases

Newspaper article The Canadian Press

Public Health Agency Gives Spain, Norway ZMapp-Like Drug to Treat Ebola Cases

Article excerpt

Canada gives Spain, Norway ZMapp-like drug

--

TORONTO - The Public Health Agency of Canada gave health officials in Spain and Norway a ZMapp-like drug to treat two health-care workers infected with Ebola, the agency confirmed Tuesday.

The National Microbiology Laboratory in Winnipeg sent Spain and Norway one treatment course each of ZMab, a monoclonal antibody cocktail developed at the lab.

The supplies of the drug were what is called laboratory grade and had been made for research in animals. Drugs used in humans are made to the rigorous standards known as current good manufacturing practices or cGMP.

It is uncommon to treat humans with laboratory grade drugs, an expert who asked not to be named acknowledged.

"Yeah, it's unusual. But it's an unusual time," the expert said.

A spokesperson for the Public Health Agency said the product was supplied to Spain and Norway on the request of the two countries.

Spain was looking for an experimental drug to treat a nursing assistant who was infected while caring for one of Spain's two cases, both priests who contracted Ebola while working at a treatment facility in West Africa. And Norway was seeking treatment for a Norwegian nurse who was infected while working for Medecins Sans Frontieres -- Doctors Without Borders -- in Sierra Leone.

"The experimental treatment was donated on compassionate grounds to help treat health-care workers infected with Ebola," the Public Health Agency said in an emailed response to questions.

"Canada has a limited amount of experimental treatment remaining available at this time. All remaining inventory will be kept in Canada for research purposes or for compassionate use by Canadians as needed."

It is not clear whether either health-care worker has received the treatment.

Media reports from Spain have presented a conflicting picture about whether the woman there actually received the drug. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.